Clik here to view.
Big boost for regenerative medicine
Human neurons developed from iPS cells (Dr. A. Hotta) Ever since the pioneering work of McCulloch and Till in the early 1960s, Ontario has been a powerhouse in stem cell science and regenerative...
View ArticleClik here to view.
MaRS Innovation staff member Jackie Terry on her Olympic legacy
Note: This post originally appeared on the MaRS Innovation website. It has been reposted here with permission from the author. Olympians from all over the world are gathering in London, England for...
View ArticleClik here to view.
OtoSim Inc. is all ears when opportunity knocks
MaRS Innovation’s portfolio includes approximately 20 companies in various stages of business development. Of these, Xagenic Inc., VitalHub Inc. and OtoSim Inc. were our initial group of incorporated...
View ArticleClik here to view.
ApneaDX: First we take Ontario, then we take the world
As 2012 winds down, ApneaDx Inc. is gearing up to make a splash in 2013. This startup—which was spun off from University Health Network (UHN) research and technology with early-stage investment and...
View ArticleClik here to view.
DLVR: Using personalized medicine and nature’s cellular toolkit to target...
Today is World Cancer Day, an initiative of the Union for International Cancer Control (UICC) that provides an opportunity to discuss how we can take control of cancer and help stop myths, confusion...
View ArticleClik here to view.
What does MaRS Innovation’s funding extension mean for Toronto’s academic...
Created in 2008, MaRS Innovation (MI) bridges the chasm between the early-stage technologies emerging from its 16 member institutions and successful startup companies and licensable technologies. By...
View ArticleClik here to view.
MaRS Innovation celebrates $15-million funding extension
On September 9, 2013, MaRS Innovation held a reception to formally celebrate its successful $15-million extension from the Networks of Centres of Excellence’s Centres of Excellence for the...
View ArticleClik here to view.
MaRS Innovation top 10 for 2013
2013 was an exceptional year for MaRS Innovation, the commercialization agent for 16 of Toronto’s leading academic institutions. Here are the top 10 news stories from our commercialization portfolio....
View ArticleClik here to view.
MaRS Startup Library adds new resources on commercialization programs and...
One question commonly asked by researchers and technology transfer/commercialization officers in academic institutions is: What resources can we leverage to support our grant applications, help...
View Article
